⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 8, 2024

[Clinicopathological features of breast cancer with HER2 low expression: a real-world retrospective study].

Kong M. Li Shafei Wu Mei Sun H X Zhang Xiao Teng Y Y Liu Zhenwei Liang Xiaofeng Zeng

View at Publisher

Ask AI

Bookmark

Share

Abstract

To investigate the clinical and pathological characteristics of breast cancer with HER2 low expression.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e61080b6db6435875a352e https://doi.org/10.3760/cma.j.cn112151-20240315-00167

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Landscape of HER2-low breast cancer: Insights from a six-year study on incidence and clinicopathological characteristics.2024 · 3 citations
2Abstract PO2-02-07: Clinicopathological Features and Prognostic Role of HER2 Low in Early Breast Cancer: A real world study2024
3Abstract PO5-25-10: Clinical and Epidemiologic Significance of HER2-Low Expression in Breast Cancer in the Pathways Study2024
4Abstract PO2-01-02: Clinicopathologic features and prognosis of breast cancer with low HER2 expression evaluated by fluorescence in situ hybridization2024
5Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancerCohort Study · 2026

Abstract PO3-01-11: Clinical Significance of HER2-low Breast Cancer2024
[Biological characteristics of triple negative breast cancer with low expression of HER2].2024
Abstract PO1-24-03: The clinicopathological and prognostic significance of HER2-low breast cancer: A comparative analysis between HER2-low and HER2-zero subtypes2024